{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:02:47Z","timestamp":1773115367164,"version":"3.50.1"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,3,15]]},"DOI":"10.2169\/internalmedicine.5761-20","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:08:14Z","timestamp":1603231694000},"page":"945-951","source":"Crossref","is-referenced-by-count":6,"title":["Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy"],"prefix":"10.2169","volume":"60","author":[{"given":"Yukiko","family":"Ochiai","sequence":"first","affiliation":[{"name":"Department of Neurology and Stroke Medicine, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Tsunogae","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke Medicine, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke Medicine, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"1. Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer 121: 664-672, 2015.","journal-title":"Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lee YG, Lee E, Kim I, et al. Cisplatin-based chemotherapy is a strong risk factor for thromboembolic events in small-cell lung cancer. Cancer Res Treat 47: 670-675, 2015.","DOI":"10.4143\/crt.2014.045"},{"key":"3","unstructured":"3. Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol 29: 3466-3473, 2011."},{"key":"4","unstructured":"4. Machleder HI, Takiff H, Lois JF, Holburt E. Aortic mural thrombus: an occult source of arterial thromboembolism. J Vasc Surg 4: 473-478, 1986."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pagni S, Trivedi J, Ganzel BL, et al. Thoracic aortic mobile thrombus: is there a role for early surgical intervention? Ann Thorac Surg 91: 1875-1881, 2011.","DOI":"10.1016\/j.athoracsur.2011.02.011"},{"key":"6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","volume":"110","author":"A Varki","year":"2007","unstructured":"6. Varki A. Trousseau&apos;s syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723-1729, 2007.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology 62: 2025-2030, 2004.","DOI":"10.1212\/01.WNL.0000129912.56486.2B"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42: 296-300, 1985.","DOI":"10.1159\/000226049"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Moorjani N, Rubens M, Price S, DeSouza A. Mobile thrombus in the ascending aorta following cisplatin-based chemotherapy. J Card Surg 28: 48-49, 2013.","DOI":"10.1111\/jocs.12034"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yagyu T, Naito M, Kumada M, Nakagawa T. Aortic mural thrombus in the non-atherosclerotic aorta of patients with multiple hypercoagulable factors. Intern Med 58: 381-385, 2019.","DOI":"10.2169\/internalmedicine.0691-17"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/6\/60_5761-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T03:52:20Z","timestamp":1616212340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/6\/60_5761-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5761-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]}}}